Company Data

MiNK Therapeutics Inc.

Ticker
INKT
Current Price
$7.1
Market Cap
$28.3M
Price Target
Refer to Report
Volume
1.3K
52wk Range
$4.5601 - $13.79
Advanced Market Data

Overview

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy